About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

MR-HIFU for Recurrent Gynaecological Cancer

NCT02714621·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Institute of Cancer Research, United Kingdom

Age

18–any

Sex

FEMALE

Healthy volunteers

Not accepted

You may be eligible if

Patients with recurrent pelvic gynaecological malignancy (cervix and endometrial cancer).
Recurrent lesion is painful (NRS\>4) and not suitable for alternative treatments
Intended target volume accessible for MRgHIFU treatment
Intended target volume visible on noncontrast MR imaging
Distance between target and skin ≥1cm

You may not be if

MRI contraindicated (e.g. by incompatible metal implants or claustrophobia)
Pregnancy
Sedation contraindicated
MRI contrast agent contraindicated
Scar, internal or external fixation device along the beam path or at the target

The record

StatusCompleted

PhaseNo phase

Taking part31

StartedMay 2016

UpdatedJul 15, 2020

Conditions

Cervical Cancer Endometrial Cancer Uterine Cancer Ovarian Cancer Vaginal Cancer+1

Where1

The Royal Marsden NHS Foundation Trust
Sutton, Surrey, United Kingdom

Clareo Health | MR-HIFU for Recurrent Gynaecological Cancer